MBX Biosciences, Inc. Common Stock

MBX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$22-$19-$24-$16
Dep. & Amort.$0-$1$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$2$2$1
Change in WC$1$1$1-$1
Other Non-Cash-$3$0-$1-$1
Operating Cash Flow-$22-$17-$23-$16
Investing Activities
PP&E Inv.-$0-$1-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$47-$59-$88
Inv. Sales/Matur.$0$73$57$20
Other Inv. Act.$17$1$5$0
Investing Cash Flow$17$26$3-$67
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$1$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$188$0$0-$0
Financing Cash Flow$188$1$0-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$183$10-$19-$84
Supplemental Information
Beg. Cash$40$30$49$133
End Cash$223$40$30$49
Free Cash Flow-$22-$18-$23-$16